Skip to main content
Equibles

Allianz Asset Management GmbH

Position in ABT — Abbott Laboratories

CIK 1535323 MUNICH, 2M
Back to ABT Full portfolio

Position in ABT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$370,966,623
-$52,452,155 QoQ
Shares Held
4,088,237
-0.9% QoQ
Ownership
0.235%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#50
of 2,966 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 58% Shared 0% None 42%

Common Shares in ABT Over Time

Shares Held

Position Value (USD)

Derivatives in ABT

reported options exposure · as of Jun 30, 2026
CallValue
$10,326,212
CallShares
113,800
PutValue
$15,380,430
PutShares
169,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Jun 30, 2026

Allianz Asset Management GmbH holds $1,031,639,723 across 20 Medical Devices names. ABT ranks #1 (36.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
This page 		4,088,237 $370,966,623
2 EW
Edwards Lifesciences Corp
 1,960,525 $177,349,089
3 MDT
Medtronic plc
 1,490,013 $116,563,715
4 BSX
Boston Scientific Corp
 2,400,485 $102,452,697
5 DXCM
Dexcom Inc
 819,497 $55,193,122
6 PODD
Insulet Corp
 247,097 $37,620,518
7 SYK
Stryker Corp
 96,801 $30,476,825
8 GEHC
GE HealthCare Technologies Inc.
 413,056 $26,439,714

All Filings in ABT

Export CSV
46 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,326,212 113,800
2026-06-30 $370,966,623 4,088,237
2026-06-30 $15,380,430 169,500
2026-03-31 $423,418,778 4,124,075
2026-03-31 $11,006,224 107,200
2026-03-31 $8,398,406 81,800
2025-12-31 $530,448,790 4,233,768
2025-12-31 $11,426,448 91,200
2025-12-31 $15,160,090 121,000
2025-09-30 $6,161,240 46,000
2025-09-30 $10,621,442 79,300
2025-09-30 $486,128,129 3,629,447
2025-06-30 $11,329,633 83,300
2025-06-30 $494,150,441 3,633,192
2025-06-30 $7,371,742 54,200
2025-03-31 $16,965,935 127,900
2025-03-31 $11,938,500 90,000
2025-03-31 $397,742,796 2,998,438
2024-12-31 $353,992,334 3,129,629
2024-12-31 $8,788,647 77,700
2024-12-31 $4,535,711 40,100
2024-09-30 $6,852,001 60,100
2024-09-30 $8,983,988 78,800
2024-09-30 $309,619,805 2,715,725
2024-06-30 $5,268,237 50,700
2024-06-30 $252,399,362 2,429,019
2024-06-30 $5,185,109 49,900
2024-03-31 $253,459,980 2,229,984
2024-03-31 $204,588 1,800
2024-03-31 $261,418 2,300
2023-12-31 $198,936,664 1,807,365
2023-09-30 $153,933,195 1,589,398
2023-06-30 $157,832,285 1,447,737
2023-03-31 $181,470,070 1,792,120
2022-12-31 $186,769,477 1,701,152
2022-09-30 $162,686,069 1,681,336
2022-06-30 $329,442,009 3,032,140
2022-03-31 $350,982,021 2,965,377
2021-12-31 $379,686,963 2,697,790
2021-09-30 $238,205,953 2,016,473
2021-06-30 $242,453,450 2,091,378
2021-03-31 $284,471,037 2,373,757
2020-12-31 $274,718,402 2,509,073
2020-09-30 $188,616,970 1,733,134
2020-06-30 $160,979,062 1,760,681
2020-03-31 $139,252,553 1,764,701

Report a Problem

Category
Description
Email (optional, for follow-up)